Standardised incidence ratios (SIRs) for cancer after renal transplant in systemic lupus erythematosus (SLE) and non-SLE recipients

OBJECTIVE: We investigated malignancy risk after renal transplantation in patients with and without systemic lupus erythematosus (SLE). METHODS: Using the United States Renal Data System from 2001 to 2009, 143 652 renal transplant recipients with and without SLE contributed 585 420 patient-years of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramsey-Goldman, Rosalind, Brar, Amarpali, Richardson, Carrie, Salifu, Moro O, Clarke, Ann, Bernatsky, Sasha, Stefanov, Dimitre G, Jindal, Rahul M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Lupus Nephritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908873/
https://www.ncbi.nlm.nih.gov/pubmed/27335659
http://dx.doi.org/10.1136/lupus-2016-000156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908873/
https://www.ncbi.nlm.nih.gov/pubmed/27335659
http://dx.doi.org/10.1136/lupus-2016-000156

Ejemplares similares